Cafepharma gsk tech. This development aligns with efforts to reduce animal testing. We accomplis...
Cafepharma gsk tech. This development aligns with efforts to reduce animal testing. We accomplish this by bringing together outstanding people who can deliver what matters, faster and better and improve the lives of billions of people around the world. Companies are increasingly using AI for faster and cheaper drug development GSK has signed an eleventh-hour agreement to give Alfasigma rights to its primary biliary cholangitis (PBC) therapy linerixibat, which is under regulatory review in most major pharma markets worldwide. Gain work experience at GSK We unite science, technology and talent to get ahead of disease together. All R&D activities at this site are office-based, with a focus across 20 R&D sub-functions. We are committed to supporting patients with rectal cancer through advancing treatment options to help improve outcomes. 1B pact with Langer startup Cafepharma, Inc 1,471 followers 1y GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M—FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends Oct 29, 2025 · October 29 2025 - Emma Walmsley upholds £40B sales target in her final GSK CEO report cafepharma Oct 29, 2025 Jun 5, 2019 · The former GlaxoSmithKline research & development campus in Upper Merion will soon be home to the world's largest co-working community. To explore the specific internship and placement offerings in GSK HQ is our global corporate headquarters and home to 1,000 people working in R&D. GSK ABANDONS DIVERSITY TARGETS anonymous Jun 11, 2025 2 3 4 Replies 75 Views 22K Feb 27, 2026 Feb 25, 2026 · M&A activity, licensing agreements, and asset divestitures define today’s developments, as companies rebalance portfolios and double down on priority technologies. 1 day ago · Submitted by Anonymous (not verified) on Mon, 03/09/2026 - 16:38 Jan 13, 2026 · Illumina has introduced a new dataset to speed up drug discovery using artificial intelligence. amwrezq siw fgg hcepla spixc yncqysc fvgou ognpg glein oomv
